个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
专注于肿瘤纳米药物的研究工作,近5年以第一/通讯作者发表论文8篇,总影响因子80.2。主持国家自然科学基金青年项目一项。
Ourresearch was focus on the development of nanomedicine. We have published 8papers as first/corresponding author in the past 5 years. Served as theprincipal investigator for a NSFC project.
文章列表:
(1) Zhou, Z. h.; Zhou, X. y.; Zhang, Y. y.;Zhao, T. C.; Li, J.; Zhong, L. p.; Pang, Y. c. Macrophage‐Capturing Self‐Assembly PhotosensitizerNanoparticles Induces Immune Microenvironment Re‐Programming and Golgi‐Responsive Immunogenic Cell Death in Head and Neck Carcinoma.Advanced Healthcare Materials 2024, 13 (20). DOI: 10.1002/adhm.202400012.
(2) Pang, Y.; Su, L.; Fu, Y.; Jia, F.;Zhang, C.; Cao, X.; He, W.; Kong, X.; Xu, J.; Zhao, J.; et al. Inhibition offurin by bone targeting superparamagnetic iron oxide nanoparticles alleviatedbreast cancer bone metastasis. Bioactive Materials 2021, 6 (3), 712-720. DOI:10.1016/j.bioactmat.2020.09.006.
(3) Pang, Y.-c.; Qiu, X.; Liu, S.; Huo, Y.;Yang, X.; Ma, C.; qi, M.; Chen, X.; Zhou, Z.-h.; Lv, Z. Golgi-triggeredradiation sensitizer retention enhances the efferocytosis and immunotherapy inbreast cancer with skeleton metastases. Chemical Engineering Journal 2024, 480.DOI: 10.1016/j.cej.2023.147818.
(4) Zhou, Z.; Chen, X.; Chen, X.; Qin, A.;Mao, Y.; Pang, Y.; Yu, S.; Zhang, S. PP121 suppresses RANKL-Induced osteoclastformation in vitro and LPS-Induced bone resorption in vivo. Experimental CellResearch 2020, 388 (2). DOI: 10.1016/j.yexcr.2020.111857.
(5) Chen, X.; He, W.; Sun, M.; Yan, Y.;Pang, Y.; Chai, G. STING inhibition accelerates the bone healing process whileenhancing type H vessel formation. The FASEB Journal 2021, 35 (11). DOI:10.1096/fj.202100069RR.
(6) Xu, W.; Chen, X.; Wang, Y.; Fan, B.;Guo, K.; Yang, C.; Yu, S.; Pang, Y.; Zhang, S. Chitooligosaccharide inhibitsRANKL‐inducedosteoclastogenesis and ligation‐induced periodontitis by suppressing MAPK/ c‐fos/NFATC1 signaling. Journal ofCellular Physiology 2019, 235 (3), 3022-3032. DOI: 10.1002/jcp.29207.
(7) Zhou, Z.-h.; Liang, S.-y.; Zhao, T.-c.;Chen, X.-z.; Cao, X.-k.; Qi, M.; Huang, Y.-y.; Ju, W.-t.; Yang, M.; Zhu, D.-w.;et al. Overcoming chemotherapy resistance using pH-sensitive hollow MnO2nanoshells that target the hypoxic tumor microenvironment of metastasized oralsquamous cell carcinoma. Journal of Nanobiotechnology 2021, 19 (1). DOI:10.1186/s12951-021-00901-9.
(8) Pang, Y.; Fu, Y.; Li, C.; Wu, Z.; Cao,W.; Hu, X.; Sun, X.; He, W.; Cao, X.; Ling, D.; et al. Metal–Organic Framework Nanoparticles forAmeliorating Breast Cancer-Associated Osteolysis. Nano Letters 2020, 20 (2),829-840. DOI: 10.1021/acs.nanolett.9b02916.
(9) Chen, R.; Liu, G.; Sun, X.; Cao, X.;He, W.; Lin, X.; Liu, Q.; Zhao, J.; Pang, Y.; Li, B.; et al. Chitosan derivednitrogen-doped carbon dots suppress osteoclastic osteolysisviadownregulatingROS. Nanoscale 2020, 12 (30), 16229-16244. DOI: 10.1039/d0nr02848g.

文件上传中...